STUDY PROTOCOL
Sexually transmitted infections among key
populations in India: A protocol for systematic
review
Mihir Bhatta
ID
1
, Agniva Majumdar
ID
1
, Utsha Ghosh
1
, Piyali Ghosh
1
, Papiya Banerji
1
,
Santhakumar Aridoss
ID
2
, Abhisek Royal
3
, Subrata Biswas
ID
1
*, Bhumika
Tumkur Venkatesh
4
, Rajatsuvra Adhikary
3
, Shanta Dutta
5
1 Division of Virology, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India, 2 Division of
Computing and Information Science, ICMR-National Institute of Epidemiology, Chennai, India, 3 World
Health Organization, New Delhi, India, 4 Campbell Collaboration, South Asia, New Delhi, India, 5 Division of
Bacteriology, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India
Abstract
Background
Sexually transmitted infections (STIs) are one of the leading causes of health, and economic
burdens in the developing world, leading to considerable morbidity, mortality, and stigma.
The incidence and prevalence of the four curable STIs viz. syphilis, gonorrhoea, chlamydia,
and trichomoniasis vary remarkably across different geographical locations. In India, the
prevalence of four curable STI among general populations is in between 0 to 3.9 percent.
However, it is assumed that STI prevalence is much higher among subpopulations practic-
ing high-risk behaviour. Like men who have sex with men (MSM), transgender (TG), inject-
ing drug users (IDU), and female sex workers (FSW).
Objectives
In the present circumstances, a systematic review is necessary to integrate the available
data from previously published peer-reviewed articles and published reports from several
competent authorities to provide the prevalence and geographical distribution of the four
curable STIs among the key population of India.
Methods
All available articles will be retrieved from PubMed, Google Scholar, Cochrane database,
Scopus, Science Direct, and the Global Health network using the appropriate search terms.
The data will be extracted through data extraction form as per PICOS (population, interven-
tion, comparison, outcome, study design) framework. Risk of bias and quality assessment
will be performed according to the situation with the help of available conventional protocol.
Discussion
The future systematic review, generated from the present protocol, may provide evidence of
the prevalence and geographical distribution of the four curable STIs among the key
PLOS ONE
PLOS ONE | https://doi.org/10.1371/journal.pone.0279048 March 13, 2023 1 / 8
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPEN ACCESS
Citation: Bhatta M, Majumdar A, Ghosh U, Ghosh
P, Banerji P, Aridoss S, et al. (2023) Sexually
transmitted infections among key populations in
India: A protocol for systematic review. PLoS ONE
18(3): e0279048. https://doi.org/10.1371/journal.
pone.0279048
Editor: Addisu Melese Dagnaw, Bahir Dar
University, ETHIOPIA
Received: November 28, 2022
Accepted: February 21, 2023
Published: March 13, 2023
Peer Review History: PLOS recognizes the
benefits of transparency in the peer review
process; therefore, we enable the publication of
all of the content of peer review and author
responses alongside final, published articles. The
editorial history of this article is available here:
https://doi.org/10.1371/journal.pone.0279048
Copyright: © 2023 Bhatta et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: No datasets were
generated or analysed during the current study. All
relevant data from this study will be made available
upon study completion.
population of India. We hope that the findings of the future systematic review will strengthen
the existing surveillance system in India, to determine the above-mention STIs prevalence
among key populations in India.
Protocol registration number: International Prospective Register for Systematic
Reviews (PROSPERO) number CRD42022346470.
Introduction
According to a recent estimate by World Health Organization (WHO), approximately three
hundred seventy million new sexually transmitted infections (STIs) occur each year around
the world, and almost half of the infected individuals are young in their age [1]. For the suitable
planning and execution of sexually transmitted disease (STD) control strategies, a proper
understanding of the patterns of STDs, prevailing at different geographic pockets is required
[2]. Individuals suffering from STIs are not only susceptible to getting infected with HIV but
also play an important role in the transmission of STIs and HIV to others [3, 4].
Recent research indicates synergy between bacterial STIs and HIV transmission and acqui-
sition and in turn enhances transmission and or acquisitions of HIV among high-risk groups
(HRGs) who have sex with men (MSM), transgender (TG), injecting drug users (IDU), and
female sex workers (FSW) [2]. According to WHO [1], more than thirty different bacteria,
viruses, and parasites are transmitted sexually. Among them, eight are selected as the promi-
nent causal agent of sexually transmitted diseases. Between these eight, four are curable viz.
syphilis, gonorrhoea, chlamydia, and trichomoniasis [5]. The other four are incurable viz. hep-
atitis B, herpes simplex virus (HSV or herpes), HIV, and human papillomavirus (HPV) [5].
STIs are spread through unprotected sexual contact, which includes vaginal, anal, and oral
routes. Certain organisms are also transmitted through maternal lineage during pregnancy,
childbirth, and breastfeeding. Mother-to-child transmission of STIs has effects like stillbirth,
neonatal death, low-birth weight and prematurity, sepsis, pneumonia, neonatal conjunctivitis,
and congenital deformities [6]. People with STIs rarely show the symptoms of the disease.
General symptoms of STIs, are abdominal pain, urethral discharge or burning in men, vaginal
discharge, and genital ulcers. STIs remain a major public health challenge for people belonging
to high-risk groups (for HIV) around the world [6]. During the last twenty years, the National
AIDS Control Organization (NACO) has undertaken the prevention of STIs as one of its key
strategies in India [7]. NACO through its network of more than eleven hundred designated
clinics branded as Suraksha Clinics, located mostly at the district-level government healthcare
facilities provides free sexual and reproductive health services based on syndromic case man-
agement through trained counsellors, expert paramedics, and experienced medical personnel
[8].
NACO is the authority for the management of STI to ensure consistency of service across
all facilities, over the country. The recently released strategy document of NACP Phase-V rein-
forces the STI component in terms of the elimination of vertical transmission of HIV and
syphilis [8]. In India, the prevalence of four curable STIs among general populations is less
than four percent, but the STI burden is probably much higher among subpopulations practic-
ing high-risk behaviour like MSM, TGs, IDU, and FSWs. There is limited literature on STI
prevalence among key populations across India but of course there are still relevant studies
available these data have not been integrated to depict the overall spatial and temporal trends
of STI infections among various key populations [9]. In the present circumstances, a system-
atic review (or if possible and meta-analysis) is needed to integrate the available data from
PLOS ONE
A protocol for systematic review on STIs among key populations in India
PLOS ONE | https://doi.org/10.1371/journal.pone.0279048 March 13, 2023 2 / 8
Funding: Fund for this research is provided by
WHO-India (Reg. No. 2022/1250989). Moreover,
the funders had no role in the study design, data
collection, analysis, the decision to publish, or the
preparation of the manuscript.
Competing interests: he authors have declared
that no competing interests exist.
previously published peer-reviewed articles and published reports from several competent
authorities [9]. The present protocol for a systematic review is set against this background and
intended to include an intensive consultation with various experts, program managers, and
representatives of key populations to recognize the present prevalence and geographic distri-
bution of STIs among key populations in India. The present findings would be vital for
enlightening STI status among high-risk group people and designing evidence-based strategies
and programs for STI prevention in high-risk group people in India.
Objective
The objectives of the present study are as follows:
A. Synthesize evidence on the prevalence of four curable STIs viz. syphilis, gonorrhoea, chla-
mydia, and Trichomoniasis (caused by Treponema pallidum, Neisseria gonorrhoeae (NG),
Chlamydia trachomatis (CT), and Trichomonas vaginalis (TV) respectively) among FSW,
MSM, IDU and H/TG populations in India.
B. Perform a Systematic Review (and Meta-analysis, upon the availability of necessary data)
on existing evidence of the prevalence (pooled prevalence, in case of meta-analysis) as well
as the geographical distribution of four curable STIs among key populations in India from
previously published articles.
Materials and methods
A study protocol is developed following Preferred Reporting Items for Systematic Reviews and
Meta-Analysis (PRISMA) guidelines [10]. The protocol is registered in the PROSPERO [11],
International Prospective Register of Systematic Reviews with the registration number
CRD42022357425 [12].
Review questions
i. What is the current prevalence of four curable sexually transmitted infections such are,
syphilis, gonorrhea, chlamydia and Trichomoniasis (caused by Treponema pallidum, Neis-
seria gonorrhoeae (NG), Chlamydia trachomatis (CT), and Trichomonas vaginalis (TV)
respectively), among the key populations (FSW, MSM, H/TG, and IDU) in India?
ii. What is the distribution of four curable sexually transmitted infections at the different geo-
graphical locations/ representations across India?
Inclusion criteria
PICOS (population, intervention, comparison, outcome, study design) framework is used for
defining systematic review questions according to the method described by the Cochrane
Handbook for Systematic Reviews of Interventions version 6.3 [13]. Any article published in
peer-reviewed journals, any reports by the government or authorized and competent non-gov-
ernmental agencies during the accepted timeline (i.e., January 2001 to December 2022).
Population.
i. The population belongs to the key population, which are FSW, MSM, H/TG and IDU in
India (as per NACO Case definition).
ii. Adults and young people aged 18 years and over.
PLOS ONE
A protocol for systematic review on STIs among key populations in India
PLOS ONE | https://doi.org/10.1371/journal.pone.0279048 March 13, 2023 3 / 8
iii. Women, men, and transgender.
Intervention. Not relevant to this review of observational studies.
Comparison group. Not relevant to this review.
Outcome. Individual and/or cumulative pooled prevalence of four curable sexually trans-
mitted infections are, Treponema pallidum, Neisseria gonorrhoeae (NG), Chlamydia trachoma-
tis (CT) and Trichomonas vaginalis (TV) among the key populations (FSW, MSM H/TG and
IDU) across different geographical regions in India.
Study design. Data will be extracted through a previously prepared Data Extraction Form
which includes different levels of data accumulation to obtain a general picture of four curable
STIs among the key population belonging to different geographical regions in India, from pre-
viously published articles divided into cross-sectional or baseline studies on different key pop-
ulation or cohort studies and different state/ central government reports regarding these four
curable STIs among FSW, MSM H/TG and IDU. After the completion of data extraction, data
will be analysed and a cumulative report of the systematic review will be generated.
Exclusion criteria
i. Countries other than India;
ii. Serological and syndromic studies, sampling other than these four curable STIs;
iii. The study population does not belong to FSW, MSM, H/TG, and IDU;
iv. Any article does not contain data on either/any four curable STIs among FSW, MSM, H/
TG, and IDU;
v. Articles published not within the accepted timeline;
vi. Participants aged less than 18 years;
vii. Commentaries and editorials.
Search strategies and selection process
Electronics databases. The following databases will be searched from January 2001 to
December 2022 for published articles in English language. The search will be updated before
initiating a statistical analysis.
a. MEDLINE
b. Cochrane Library
c. Psychinfo
d. Science Direct
e. Scopus
f. EMBASE
g. Google Scholar and
h. PUBMED
PLOS ONE
A protocol for systematic review on STIs among key populations in India
PLOS ONE | https://doi.org/10.1371/journal.pone.0279048 March 13, 2023 4 / 8
Grey literature. An extensive search will be carried out through the following reports rele-
vant to the study.
a. Annual reports of NACO
b. Reports by SANKALAK (NACO)
c. Annual reports of UNAIDS
d. Annual reports of WHO
e. Annual reports of UNDP
f. Annual reports of ICMR
g. Ganga Social Foundation
h. West Bengal State AIDS Prevention and Control Society
i. Tamil Nadu State AIDS Prevention Control Society
j. Annual reports of Delhi State AIDS Control Society
k. State reports of Kerala, Rajasthan
l. MGVS annual report
m. KSAPS annual report
Inclusion of studies from Grey literature will be carried out after being checked through a
quality assessment tool (Axis Tool) [14].
Search terms
Search terms are provided in S1 File
Additional searches
i. Reference lists: if retrieved publications will be include source references for potential stud-
ies about the prevalence of four curable STIs on any members of the Key population, the
originals will be retrieved;
ii. Experts in the field will be contacted to ask if they know of any additional publications,
which will not be identified by the search strategy.
De-duplication
i. Mendeley [15], a bibliographic application will be used for reference management.
ii. The following rules will be used to remove duplicate hits from the database
iii. Title, or various combinations of the author, year, secondary title, volume, issue, and pages
will be compared through the ‘de-duplication’ process
iv. The full records of suspected duplicates will be compared visually
v. Duplicate entries will be saved in a separate MS Word file
PLOS ONE
A protocol for systematic review on STIs among key populations in India
PLOS ONE | https://doi.org/10.1371/journal.pone.0279048 March 13, 2023 5 / 8
Selection of eligible studies
Titles and abstracts of articles selected through the search strategy will be screened by two
reviewers independently, applying the inclusion and exclusion criteria. Any article selected as
being probably qualified will be taken for the full text review. Where no abstract will be avail-
able electronically, and eligibility could not be judged from the title alone, the full text of the
article will be retrieved and screened. The abstracts of articles identified through additional
searches will be reviewed in the same manner as those identified through database searches.
Data will be extracted by data extraction form.
Strategy for data synthesis
The data will be extracted from full-text published articles according to the Preferred Report-
ing Items for Systematic Reviews and Meta-Analysis (PRISMA). With the help of Epi Info—
(Ver. 6.0) generated modified data extraction form [16].
Assessment of the methodological quality
Evaluation of articles through name, abstract, and entire text of the selected articles will be per-
formed prior to the addition of it in the ultimate analysis. Assessment will be performed with
the help of a modified Newcastle—Ottawa Quality Assessment Scale [17].
Publication bias analysis
To evaluate publication bias Egger’s [18] and Begg and Mazumdar’s [19] assessments will be
used along with the Funnel diagram.
Descriptive analysis
The prevalence (pooled prevalence in case of meta-analysis) estimation will be done from each
study on above mentioned four curable sexually transmitted infections among the key popula-
tions in India.
Strength and limitations of the study
Like any systematic review, the present study will also be restricted by the comprehensiveness
of the published articles and whether workers published their study in open accessed and peer-
reviewed journals as well as available reports from various agencies. Moreover, future included
articles that will be included as per the current protocol may have to contain surveys that accu-
mulate biological data leaving an approach for further studies.
Expected outcomes
The future systematic review, which will be generated from the present protocol, may provide
evidence on the current prevalence (pooled prevalence in case of meta-analysis) and present
geographical distribution of four curable STIs viz. Syphilis, Gonorrhoea, Chlamydia, and
Trichomoniasis among key populations in India.
Discussions
The future systematic review, which will be generated from the present protocol, may provide
evidence of the prevalence and geographical distribution of the four curable STIs among the
key population of India. The findings of the future systematic review will strengthen the exist-
ing surveillance system under NACP-V (fifth phase of National AIDS Control Programme
PLOS ONE
A protocol for systematic review on STIs among key populations in India
PLOS ONE | https://doi.org/10.1371/journal.pone.0279048 March 13, 2023 6 / 8
under the supervision of NACO, Government of India. This phase is renamed as National
AIDS & STI Control Programme), to determine the above-mentioned STIs prevalence among
key populations in India. The present protocol might be handy to conduct a systemic review of
the prevalence and geographical distribution of the four above-mentioned bacterial STIs
among the general population in India.
Supporting information
S1 Checklist. PRISMA-P (Preferred Reporting Items for Systematic review and Meta-
Analysis Protocols) 2015 checklist: Recommended items to address in a systematic review
protocol
.
(PDF)
S1 File. Search terms and strategy.
(DOCX)
S2 File. Data extraction form.
(DOCX)
Author Contributions
Conceptualization: Mihir Bhatta, Subrata Biswas, Bhumika Tumkur Venkatesh, Rajatsuvra
Adhikary, Shanta Dutta.
Data curation: Mihir Bhatta, Utsha Ghosh, Piyali Ghosh, Papiya Banerji, Subrata Biswas.
Formal analysis: Utsha Ghosh, Piyali Ghosh, Papiya Banerji.
Funding acquisition: Abhisek Royal, Rajatsuvra Adhikary, Shanta Dutta.
Investigation: Mihir Bhatta, Utsha Ghosh, Piyali Ghosh, Papiya Banerji, Santhakumar Ari-
doss, Subrata Biswas.
Methodology: Mihir Bhatta, Utsha Ghosh, Papiya Banerji, Santhakumar Aridoss, Subrata Bis-
was, Shanta Dutta.
Project administration: Mihir Bhatta, Subrata Biswas, Rajatsuvra Adhikary, Shanta Dutta.
Resources: Agniva Majumdar, Abhisek Royal, Rajatsuvra Adhikary, Shanta Dutta.
Supervision: Mihir Bhatta, Agniva Majumdar, Papiya Banerji, Santhakumar Aridoss, Subrata
Biswas, Bhumika Tumkur Venkatesh, Rajatsuvra Adhikary, Shanta Dutta.
Validation: Santhakumar Aridoss.
Writing – original draft: Mihir Bhatta, Utsha Ghosh, Piyali Ghosh, Papiya Banerji, Subrata
Biswas.
Writing – review & editing: Mihir Bhatta, Agniva Majumdar, Utsha Ghosh, Piyali Ghosh,
Papiya Banerji, Santhakumar Aridoss, Subrata Biswas, Shanta Dutta.
References
1. WHO. Report on global sexually transmitted infection surveillance, World Health Organization. 2018.
2. WHO. A tool for strengthening STI surveillance at the country level, World Health Organization. World
Health Organization; 2015.
3. WHO. Baseline report on global sexually transmitted infection surveillance 2012, World Health Organi-
zation. 2013.
PLOS ONE
A protocol for systematic review on STIs among key populations in India
PLOS ONE | https://doi.org/10.1371/journal.pone.0279048 March 13, 2023 7 / 8
4. WHO. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021: account-
ability for the global health sector strategies 2016–2021: actions for impact: web annex 2: data methods,
World Health Organization. 2021.
5. Newman L, Rowley J, Vander Hoorn S, Wijesooriya NS, Unemo M, Low N, et al. Global estimates of the
prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic
review and global reporting. PloS one. 2015; 10(12):e0143304. https://doi.org/10.1371/journal.pone.
0143304 PMID: 26646541
6. Rowley J, Vander Hoorn S, Korenromp E, Low N, Unemo M, Abu-Raddad LJ, et al. Chlamydia, gonor-
rhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bulletin of the
World Health Organization. 2019; 97(8):548–562P. https://doi.org/10.2471/BLT.18.228486 PMID:
31384073
7. Haldar P, Morineau G, Das A, Mehendale S, et al. A surveillance model for sexually transmitted infec-
tions in India. Indian journal of public health. 2015; 59(4):286. https://doi.org/10.4103/0019-557X.
169658 PMID: 26584168
8. NACO. Country scenario during NACP-IV, National AIDS Control Organisation, Ministry of Health and
Family Welfare: New Delhi. National AIDS Control Organisation, Ministry of Health and Family Wel-
fare: New Delhi; 2015.
9. Sexton J, Garnett G, Røttingen JA. Metaanalysis and metaregression in interpreting study variability in
the impact of sexually transmitted diseases on susceptibility to HIV infection. Sexually transmitted dis-
eases. 2005; p. 351–357. https://doi.org/10.1097/01.olq.0000154504.54686.d1 PMID: 15912081
10. Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for
systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. Bmj.
2015; 349. https://doi.org/10.1136/bmj.g7647 PMID: 25555855
11. Schiavo JH. PROSPERO: an international register of systematic review protocols. Medical reference
services quarterly. 2019; 38(2):171–180. https://doi.org/10.1080/02763869.2019.1588072 PMID:
31173570
12. Bhatta M, et al. PROSPERO registrar protocol on Systematic Review of Sexually Transmitted Infections
among Key Populations in India. ID CRD42022357425; 2022.
13. Higgins J, Chandler J, Cumpston M, Li T, Page M, Welch V. Cochrane Handbook for Systematic
Reviews of Interventions version 6.3 In. London: Cochrane. 2022.
14. Downes MJ, Brennan ML, Williams HC, Dean RS. Development of a critical appraisal tool to assess the
quality of cross-sectional studies (AXIS). BMJ open. 2016; 6(12):e011458. https://doi.org/10.1136/
bmjopen-2016-011458 PMID: 27932337
15. Zahedi Z, Costas R, Wouters P. Mendeley readership as a filtering tool to identify highly cited publica-
tions. Journal of the Association for Information Science and Technology. 2017; 68(10):2511–2521.
16. Camp B, Mandivarapu JK, Ramamurthy N, Wingo J, Bourgeois AG, Cao X, et al. A new cross-platform
architecture for epi-info software suite. BMC bioinformatics. 2018; 19(11):1–8. https://doi.org/10.1186/
s12859-018-2334-8 PMID: 30343662
17. Luchini C, Stubbs B, Solmi M, Veronese N. Assessing the quality of studies in meta-analyses: Advan-
tages and limitations of the Newcastle Ottawa Scale. World J Meta-Anal. 2017; 5(4):80–84.
18. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test.
Bmj. 1997; 315(7109):629–634. https://doi.org/10.1136/bmj.315.7109.629 PMID: 9310563
19. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Bio-
metrics. 1994; p. 1088–1101. PMID: 7786990
PLOS ONE
A protocol for systematic review on STIs among key populations in India
PLOS ONE | https://doi.org/10.1371/journal.pone.0279048 March 13, 2023 8 / 8